Back to Search Start Over

Lead generation and optimization of novel GPR119 agonists with a spirocyclic cyclohexane structure.

Authors :
Harada K
Mizukami J
Watanabe T
Mori G
Ubukata M
Suwa K
Fukuda S
Negoro T
Sato M
Inaba T
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Feb 01; Vol. 29 (3), pp. 373-379. Date of Electronic Publication: 2018 Dec 18.
Publication Year :
2019

Abstract

We describe here the generation of a lead compound and its optimization studies that led to the identification of a novel GPR119 agonist. Based on a spirocyclic cyclohexane structure reported in our previous work, we identified compound 8 as a lead compound, being guided by ligand-lipophilicity efficiency (LLE), which linked potency and lipophilicity. Subsequent optimization studies of 8 for improvement of solubility afforded representative 21. Compound 21 had no inhibitory activity against six CYP isoforms and showed favorable pharmacokinetic properties and hypoglycemic activity in rats.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
29
Issue :
3
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
30587450
Full Text :
https://doi.org/10.1016/j.bmcl.2018.12.041